rs11622977
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001355436.2(SPTB):c.6269+13C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.113 in 1,613,462 control chromosomes in the GnomAD database, including 12,992 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.16 ( 2927 hom., cov: 33)
Exomes 𝑓: 0.11 ( 10065 hom. )
Consequence
SPTB
NM_001355436.2 intron
NM_001355436.2 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.62
Publications
5 publications found
Genes affected
SPTB (HGNC:11274): (spectrin beta, erythrocytic) This locus encodes a member of the spectrin gene family. Spectrin proteins, along with ankyrin, play a role in cell membrane organization and stability. The protein encoded by this locus functions in stability of erythrocyte membranes, and mutations in this gene have been associated with spherocytosis type 2, hereditary elliptocytosis, and neonatal hemolytic anemia. Alternatively spliced transcript variants have been described. [provided by RefSeq, Nov 2009]
SPTB Gene-Disease associations (from GenCC):
- hereditary spherocytosis type 2Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- elliptocytosis 3Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- hereditary elliptocytosisInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- hereditary spherocytosisInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BP6
Variant 14-64767290-G-A is Benign according to our data. Variant chr14-64767290-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 257134.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.331 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| SPTB | NM_001355436.2 | c.6269+13C>T | intron_variant | Intron 31 of 35 | ENST00000644917.1 | NP_001342365.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.165 AC: 25018AN: 152034Hom.: 2921 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
25018
AN:
152034
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.104 AC: 26102AN: 251210 AF XY: 0.0997 show subpopulations
GnomAD2 exomes
AF:
AC:
26102
AN:
251210
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.108 AC: 157941AN: 1461310Hom.: 10065 Cov.: 33 AF XY: 0.106 AC XY: 77279AN XY: 727006 show subpopulations
GnomAD4 exome
AF:
AC:
157941
AN:
1461310
Hom.:
Cov.:
33
AF XY:
AC XY:
77279
AN XY:
727006
show subpopulations
African (AFR)
AF:
AC:
11447
AN:
33470
American (AMR)
AF:
AC:
3122
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
AC:
2575
AN:
26132
East Asian (EAS)
AF:
AC:
221
AN:
39700
South Asian (SAS)
AF:
AC:
5922
AN:
86252
European-Finnish (FIN)
AF:
AC:
4532
AN:
53060
Middle Eastern (MID)
AF:
AC:
520
AN:
5768
European-Non Finnish (NFE)
AF:
AC:
122918
AN:
1111826
Other (OTH)
AF:
AC:
6684
AN:
60382
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.461
Heterozygous variant carriers
0
7791
15581
23372
31162
38953
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
4442
8884
13326
17768
22210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.165 AC: 25053AN: 152152Hom.: 2927 Cov.: 33 AF XY: 0.160 AC XY: 11924AN XY: 74396 show subpopulations
GnomAD4 genome
AF:
AC:
25053
AN:
152152
Hom.:
Cov.:
33
AF XY:
AC XY:
11924
AN XY:
74396
show subpopulations
African (AFR)
AF:
AC:
13907
AN:
41492
American (AMR)
AF:
AC:
1525
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
AC:
357
AN:
3468
East Asian (EAS)
AF:
AC:
35
AN:
5188
South Asian (SAS)
AF:
AC:
307
AN:
4820
European-Finnish (FIN)
AF:
AC:
835
AN:
10608
Middle Eastern (MID)
AF:
AC:
37
AN:
294
European-Non Finnish (NFE)
AF:
AC:
7674
AN:
67980
Other (OTH)
AF:
AC:
291
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1016
2031
3047
4062
5078
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
258
516
774
1032
1290
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
239
AN:
3478
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Nov 28, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Elliptocytosis Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Spherocytosis, Dominant Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.